Intratumoral injection of GM-CSF in perspective - A review

Stephen Brooks, Hiroshi Takita, Kyu Shin, Yisheng Fang, Mary Vaughan, Sanjay Sharma, Constantine P. Karakousis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Reviewed evidence suggests that immunologic adjuvants released in the process of inflammation may facilitate the recognition and immune response to weak antigens such as tumor associated antigens. The mechanism of tumor progression vis-a-vis the immune system is more likely the release by the tumor cells of immunosuppressive factors locally within the tumor microenvironment rather than systemic immunosuppression. Intratumoral injection of GM-CSF results often in partial regression of the injected nodules and occasionally of non-injected nodules with marked infiltration by dendritic cells and eosinophils at injected sites. Research among the various cytokines for intratumoral injection represents a promising lead for future developments.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalJournal of Medicine
Volume34
Issue number1-6
StatePublished - 2003

Fingerprint

Granulocyte-Macrophage Colony-Stimulating Factor
Immunologic Adjuvants
Injections
Tumor Microenvironment
Neoplasm Antigens
Immunosuppressive Agents
Eosinophils
Immunosuppression
Dendritic Cells
Immune System
Neoplasms
Cytokines
Inflammation
Antigens
Research
Lead

Keywords

  • Cytokines
  • Intratumoral injection
  • Mechanism of tumor progression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brooks, S., Takita, H., Shin, K., Fang, Y., Vaughan, M., Sharma, S., & Karakousis, C. P. (2003). Intratumoral injection of GM-CSF in perspective - A review. Journal of Medicine, 34(1-6), 149-153.

Intratumoral injection of GM-CSF in perspective - A review. / Brooks, Stephen; Takita, Hiroshi; Shin, Kyu; Fang, Yisheng; Vaughan, Mary; Sharma, Sanjay; Karakousis, Constantine P.

In: Journal of Medicine, Vol. 34, No. 1-6, 2003, p. 149-153.

Research output: Contribution to journalArticle

Brooks, S, Takita, H, Shin, K, Fang, Y, Vaughan, M, Sharma, S & Karakousis, CP 2003, 'Intratumoral injection of GM-CSF in perspective - A review', Journal of Medicine, vol. 34, no. 1-6, pp. 149-153.
Brooks S, Takita H, Shin K, Fang Y, Vaughan M, Sharma S et al. Intratumoral injection of GM-CSF in perspective - A review. Journal of Medicine. 2003;34(1-6):149-153.
Brooks, Stephen ; Takita, Hiroshi ; Shin, Kyu ; Fang, Yisheng ; Vaughan, Mary ; Sharma, Sanjay ; Karakousis, Constantine P. / Intratumoral injection of GM-CSF in perspective - A review. In: Journal of Medicine. 2003 ; Vol. 34, No. 1-6. pp. 149-153.
@article{093e11429a2543c4b2eca916bbbe6afb,
title = "Intratumoral injection of GM-CSF in perspective - A review",
abstract = "Reviewed evidence suggests that immunologic adjuvants released in the process of inflammation may facilitate the recognition and immune response to weak antigens such as tumor associated antigens. The mechanism of tumor progression vis-a-vis the immune system is more likely the release by the tumor cells of immunosuppressive factors locally within the tumor microenvironment rather than systemic immunosuppression. Intratumoral injection of GM-CSF results often in partial regression of the injected nodules and occasionally of non-injected nodules with marked infiltration by dendritic cells and eosinophils at injected sites. Research among the various cytokines for intratumoral injection represents a promising lead for future developments.",
keywords = "Cytokines, Intratumoral injection, Mechanism of tumor progression",
author = "Stephen Brooks and Hiroshi Takita and Kyu Shin and Yisheng Fang and Mary Vaughan and Sanjay Sharma and Karakousis, {Constantine P.}",
year = "2003",
language = "English (US)",
volume = "34",
pages = "149--153",
journal = "Journal of Medicine",
issn = "0025-7850",
publisher = "S. Karger AG",
number = "1-6",

}

TY - JOUR

T1 - Intratumoral injection of GM-CSF in perspective - A review

AU - Brooks, Stephen

AU - Takita, Hiroshi

AU - Shin, Kyu

AU - Fang, Yisheng

AU - Vaughan, Mary

AU - Sharma, Sanjay

AU - Karakousis, Constantine P.

PY - 2003

Y1 - 2003

N2 - Reviewed evidence suggests that immunologic adjuvants released in the process of inflammation may facilitate the recognition and immune response to weak antigens such as tumor associated antigens. The mechanism of tumor progression vis-a-vis the immune system is more likely the release by the tumor cells of immunosuppressive factors locally within the tumor microenvironment rather than systemic immunosuppression. Intratumoral injection of GM-CSF results often in partial regression of the injected nodules and occasionally of non-injected nodules with marked infiltration by dendritic cells and eosinophils at injected sites. Research among the various cytokines for intratumoral injection represents a promising lead for future developments.

AB - Reviewed evidence suggests that immunologic adjuvants released in the process of inflammation may facilitate the recognition and immune response to weak antigens such as tumor associated antigens. The mechanism of tumor progression vis-a-vis the immune system is more likely the release by the tumor cells of immunosuppressive factors locally within the tumor microenvironment rather than systemic immunosuppression. Intratumoral injection of GM-CSF results often in partial regression of the injected nodules and occasionally of non-injected nodules with marked infiltration by dendritic cells and eosinophils at injected sites. Research among the various cytokines for intratumoral injection represents a promising lead for future developments.

KW - Cytokines

KW - Intratumoral injection

KW - Mechanism of tumor progression

UR - http://www.scopus.com/inward/record.url?scp=34548793428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548793428&partnerID=8YFLogxK

M3 - Article

C2 - 17882789

AN - SCOPUS:34548793428

VL - 34

SP - 149

EP - 153

JO - Journal of Medicine

JF - Journal of Medicine

SN - 0025-7850

IS - 1-6

ER -